Scholz G, Marek H, Kellner K
Abteilung Endokrinologie/Stoffwechselerkrankungen, Bereiches Medizin der Karl-Marx-Universität Leipzig.
Z Gesamte Inn Med. 1990 Jul 1;45(13):373-8.
Variations in circadian cortisol rhythm, morning ACTH concentration and the 24-hour cortisol excretion were examined in 15 healthy volunteers and 9 untreated patients with cardiovascular diseases. These variations were measured under basal conditions and during low dose (ACTHL-test) and also a high dose (ACTHH-test) ACTH stimulation. Additionally, in the patients with cardiovascular diseases the effect of verapamil-administration was investigated. Under basal conditions no significant differences were to be seen between normal subjects and the patients, either before or after therapy. The two functional tests resulted in almost identical increases of cortisol and ACTH levels, both in healthy subjects and the patients before verapamil. It was found that after verapamil application during the ACTHL-test, the levels of plasma cortisol decreased in comparison with the values noted before verapamil (p less than 0.05). However, in the ACTHH-test a significant increase of the plasma cortisol (p less than 0.05) was evident. Our results lead to the conclusion that after verapamil therapy, under slight loading, the plasma cortisol concentration can be expected to decrease slightly, and in extremely high stress situations it will increase.
对15名健康志愿者和9名未经治疗的心血管疾病患者的昼夜皮质醇节律、早晨促肾上腺皮质激素(ACTH)浓度及24小时皮质醇排泄量的变化进行了检测。这些变化在基础条件下、低剂量促肾上腺皮质激素刺激试验(ACTHL试验)及高剂量促肾上腺皮质激素刺激试验(ACTHH试验)期间进行测量。此外,还研究了心血管疾病患者服用维拉帕米后的效果。在基础条件下,正常受试者与患者在治疗前后均未观察到显著差异。两项功能试验在健康受试者和服用维拉帕米前的患者中均使皮质醇和促肾上腺皮质激素水平出现几乎相同的升高。结果发现,在ACTHL试验期间服用维拉帕米后,血浆皮质醇水平与服用维拉帕米前相比有所下降(p<0.05)。然而,在ACTHH试验中,血浆皮质醇显著升高(p<0.05)。我们的结果得出结论,维拉帕米治疗后,在轻度负荷下,血浆皮质醇浓度可能会略有下降,而在极高应激情况下则会升高。